Madam Speaker, we have shown notable transparency. Of course, we communicate dose information to the province and territories and coordinate our vaccination effort very well. Let me quote Innovative Medicines Canada, which represents a number of our vaccine suppliers. It said, “We urge all parties to respect the confidential nature of these commercial contracts which were entered into in good faith, and to ensure that commercially-sensitive and proprietary information is protected from disclosure at this critical time.”
In the House of Commons on February 19th, 2021. See this statement in context.